Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea
- 1 February 2005
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 54 (2) , 149-153
- https://doi.org/10.1099/jmm.0.45812-0
Abstract
Antibiotic-associated diarrhoea (AAD) represents a clinical entity leading to prolonged hospital stays and diagnostic and therapeutic procedures, and results in additional costs. The aim of the present study was to assess the prevalence and characteristics of different bacteria in stools of patients with AAD. The reliability of diagnostic procedures under routine conditions was evaluated. Host factors were also analysed. From June 2002 to April 2003 89 cases of diarrhoea were reported at a hospital unit for internal medicine. Clostridium difficile and Clostridium perfringens toxin enzyme-immunoassays (EIAs), and culture for C. difficile, C. perfringens and Staphylococcus aureus were performed on stool samples from all patients. Toxin production was determined in isolated S. aureus strains. In vitro susceptibility of S. aureus for oxacillin and of C. difficile for vancomycin, metronidazole, linezolid, fusidic acid and tetracycline was tested. Host factors, such as age, comorbidities, antibiotic exposure and contact with other patients, were evaluated. Twenty-six stools were positive for C. difficile toxins by an EIA technique, while C. difficile was cultured from 39. C. difficile was isolated from 21 stools that were EIA negative. Additionally, from 28 stools S. aureus and/or C. perfringens could be isolated. Nine samples contained only S. aureus and/or C. perfringens. Thirty-one stools were negative in all tests. All C. difficile isolates were susceptible to vancomycin and metronidazole. Age >60 years, and diseases of the vascular system, the heart, the kidneys and the lungs were identified as risk factors for acquiring C. difficile in this setting (P values < 0.05). Stool culture for C. difficile was shown to be more sensitive than toxin EIA in this study. Risk factors for the acquisition of C. difficile in outbreak situations seem to differ from risk factors in the normal hospital setting. The role of toxin-producing S. aureus in cases of AAD needs further investigation.Keywords
This publication has 28 references indexed in Scilit:
- A European survey of diagnostic methods and testing protocols for Clostridium difficileClinical Microbiology & Infection, 2003
- Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoeaJournal of Hospital Infection, 2003
- In vitro activity of linezolid against Clostridium difficileJournal of Antimicrobial Chemotherapy, 2003
- Reduced susceptibility ofClostridium difficileto metronidazoleJournal of Antimicrobial Chemotherapy, 2001
- Similar Frequency of Detection of Clostridium perfringens Enterotoxin and Clostridium difficile Toxins in Patients with Antibiotic-Associated DiarrheaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Clostridium difficile-associated diarrhoea in hospitalised patientsJournal of Clinical Pharmacy & Therapeutics, 2000
- Analysis of the Pathogenicity Locus inClostridium difficileStrainsThe Journal of Infectious Diseases, 2000
- Clostridium perfringens: Food poisoning and antibiotic-associated diarrheaClinical Microbiology Newsletter, 1997
- Phage susceptibility, enterotoxigenicity and antibiograms of staphylococcus aureus strains isolated from human wounds and diarrhoeaZentralblatt für Bakteriologie, 1992
- ENTEROTOXIGENIC CLOSTRIDIUM PERFRINGENS: A POSSIBLE CAUSE OF ANTIBIOTIC-ASSOCIATED DIARRHOEAThe Lancet, 1984